PATENT CLAIM ANALYSIS

Application Number: 15745714
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["549", "022000"]

Abstract:
The invention relates to Pro-drugs, comprising red-ox-sensitive cleavage sites. The compounds may be utilized in medical practice for targeting of si RNA, antisense oligonucleotides or protein-based therapeutics to the cytoplasmatic compartment of cells both in vitro or in vivo, in a subject in need.

Claim (Index 2):
A Pro-drug according to  claim 1 , comprising the structure as set forth in the general Formula (IIa) or Formula (IIb): including pharmaceutically acceptable salts, hydrates, solvates and metal chelates of the compound represented by the structure as set forth in Formula (IIa) or Formula (IIb), and solvates and hydrates of the salts, wherein A, L 1 , L 2 , L 3 , L 4 , Q 1 , Q 2 , Q 3  and Q 4  and * are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.28947
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15691821', '15222559', '14872179', '14830799', '10585928']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7325427702980405
- 35 USC 102 Novelty (BERT): 0.5085887364359684
- Combined Prediction Score: 0.7101473669118333
- Mean Citation Score: 271.216316
- Max Citation Score: 300.4459
- Similarity Product: 244.15974987353087

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test